The Syneos Health Podcast | Conversations on Commercialization
A new limited series of the Syneos Health Podcast, Conversations on Commercialization unpacks how biopharma leaders are rewriting the commercial playbook, redefining what it takes to succeed.
Recorded live at Fierce Pharma Week 2025, this special series drops you into the conversations that matter — where our experts dig deep with industry trailblazers to decode what’s working, what’s next and what leaders can’t afford to ignore.
New conversations will drop regularly—each one tackling a different pressure point in the commercial model. Bookmark this page and come back to hear more.
The views expressed in this podcast belong solely to the speakers and do not represent those of their organizations.
Want to be notified when new episodes are released?
Episode 1: The New Rules of HCP Engagement
Mark Bard, Co-Founder of Digital Health Coalition (DHC) joins host Tyler Cowan, VP, Commercial at Syneos Health, to unpack how the pandemic reshaped provider expectations and the continued impact on commercial teams. From feedback loops to content fatigue, to the myth of multichannel mastery, they break down what it takes to engage HCPs on their terms.
Episode 2: DTP, AI and the Future of Pharma Access
In part two of our conversation with Mark Bard, he and Tyler Cowan turn the lens to patients, exploring how direct-to-patient models are disrupting traditional care, and the implications of reduced physician involvement. They also tackle the rise of agentic AI, what it could enable and what commercial teams should be thinking about now.
Episode 3: GLP-1 Gold Rush — Who’s Really Winning in the New Obesity Market?
Host Tyler Cowan, VP Commercial at Syneos Health, joins Hruta Shah, Senior Engagement Manager for Syneos Health Consulting, to break down the high-stakes race in obesity treatment and the commercial boom around GLP-1 therapies.
You’ll hear:
- What emerging launch strategies look like in a crowded pipeline and how success is being redefined
- How GLP-1s are accelerating a shift in stakeholder dynamics, including telehealth, large employers and direct-to-patient platforms
- Why traditional DTC advertising is evolving and how informed patients are influencing brand messaging
